Sinovac stock runs out, Lembata can’t get a booster vaccination

Sinovac’s Covid-19 vaccine. Photo: Ricardo/JPNN.com

jpnn.com, LEMBATA – The government of Lembata Regency in East Nusa Tenggara has not been able to provide vaccines booster which nationally started on January 12, 2022.

This is because the second dose of vaccination has not fully met the target due to running out of vaccine stock.

According to the acting head of the Lembata Regency Health Office, Gabriel Bala Warat, most of the vaccines used for the first dose of vaccination in his area were Sinovac and Moderna.

However, now the Lembata Regency Government has run out of stock for the two types of vaccines for the second dose of injection. “The second dose of vaccination activities using Sinovac and Moderna vaccines has been temporarily suspended,” said Gabriel Bala Warat via WhatsApp message to JPNN.com, Saturday (15/1).

Indeed, the Lembata Regency Government still has the AstraZeneca vaccine. The stock is also available 18,530 doses

Therefore, Lembata residents who received the AstraZeneca vaccine for the first dose of injection can still get the second dose.

As of January 10, 2022, the first dose vaccination rate in Lembata has reached 84.3 percent. However, the second dose of vaccination is still at 34.16 percent.

Therefore, the Lembata Regency Government is trying to get the second dose of vaccination to reach 50 percent. Thus, administering the vaccine booster can be done immediately.

The Lembata Regency Government has run out of stock of the Sinovac and Moderna vaccines that have been used for the first stage of vaccination. As a result, Lembata has not been able to complete the second stage of vaccination or giving a booster.


Source: JPNN.com | Recent RSS Feed by www.jpnn.com.

*The article has been translated based on the content of JPNN.com | Recent RSS Feed by www.jpnn.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!